Vector Borne Diseases: Clinical Trials

39 trials for Vector Borne Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 unknown. 39 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 439Unknown 39

Follow Vector Borne Diseases: new trials by email Literature Review of Vector Borne Diseases trials Research Report on Vector Borne Diseases

Trials (filtered) newest first · largest first

All 39 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children
Mosquirixs, artemether-lumefantrine - Malaria,Falciparum
Phase 4UnknownKamuzu University of Health Sciences54002024-06-012024-05-21
Seasonal Malaria Chemoprevention Rapid Assessment Study Mozambique
Sulfadoxine/pyrimethamine plus amodiaquine - Malaria,Falciparum, Chemoprevention
Phase 4UnknownMalaria Consortium10002024-03-262024-03-29
Primary TBE Vaccination for the Elderly
FSME-IMMUN Vaccine - Tick-borne Encephalitis, Vaccine
Phase 4UnknownRegion Örebro County902024-01-012023-11-18
Chemoprevention Efficacy Study Nigeria
Standard age based SPAQ administration for SMC - Malaria
Phase 4UnknownMalaria Consortium8002023-07-282023-08-07
Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
Methylprednisolone, intravenous immunoglobulin, Tocilizumab - Severe Fever With Thrombocytopenia Syndrome
Phase 4UnknownQin Ning3502022-08-192023-07-21
Ivermectin-artemisinin Combination Therapy for Eradication of Malaria
Artemether/lumefantrine, Ivermectin - Malaria
Phase 4UnknownMakerere University1382022-08-042022-11-04
Chemoprevention Efficacy Study in Burkina Faso
Sulfadoxine pyrimethamine, Amodiaquine - Malaria
Phase 4UnknownMalaria Consortium8002022-07-152023-11-01
Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda
Sulfadoxine pyrimethamine and amodiaquine, dihydroartemisinin-piperaquine - Malaria
Phase 4UnknownMalaria Consortium68052022-06-012023-11-01
Escalating Monthly Doses of Tafenoquine in Healthy Volunteers
Tafenoquine prophylaxis - Prophylaxis
Phase 4UnknownNaval Medical Research Center2002022-05-102022-04-11
Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon
Artemether-Lumefantrine Drug Combination, Dihydroartemisinin-Piperaquine drug combination - Malaria
Phase 4UnknownUniversity of Yaounde 11842022-04-112022-04-22
Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study
Chemopreventive Agent - SPAQ, Control Test - no drugs given - Malaria
Phase 4UnknownMalaria Consortium31562022-01-082023-11-02
Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)
Artemether-lumefantrine - Malaria, Burkina Faso
Phase 4UnknownCentre national de recherche et de formation sur le paludisme10502021-06-012021-03-03
Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon
Artesunate-amodiaquine drug combination, Artemether-lumefantrine drug combination - Falciparum Malaria
Phase 4UnknownUniversity of Yaounde 11842021-04-052021-04-02
Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province
Japanese Encephalitis Vaccine (Vero Cell), Inactivated;, No prospective interventions - Japanese Encephalitis, Vaccine Preventable Disease
Phase 4UnknownZhejiang Provincial Center for Disease Control and Prevention7122021-03-012022-11-15
Optimizing Malaria Treatment for HIV-Malaria Co-infected Individuals
Artemether-lumefantrine - HIV Coinfection, Malaria
Phase 4UnknownMakerere University8882021-01-182023-01-06
Drug Combinations of Atovaquone-Proguanil (AP) With ACT
Artesunate and Pyronaridine, Atovaquone Proguanil and Artesunate Pyronaridine, Atovaquone Proguanil and Artesunate Mefloquine - Plasmodium Falciparum Malaria (Drug Resistant)
Phase 4UnknownArmed Forces Research Institute of Medical Sciences, Thailand2522018-10-042021-03-02
Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children
Azithromycin, Placebo - Pneumonia, Diarrhea
Phase 4UnknownUniversity of Washington14002016-06-282023-12-04
Malaria Elimination Pilot Study in Military Forces in Cambodia
DHA-PIP, Primaquine, Artesunate + Mefloquine - Malaria, Parasitic Diseases
Phase 4UnknownArmed Forces Research Institute of Medical Sciences, Thailand10502016-01-012021-03-02
Application of a TBE-Vaccine in Obese Persons
FSME-IMMUN Vaccine - Tick Borne Encephalitis
Phase 4UnknownMedical University of Vienna732015-04-152019-09-10
Ketotifen as a Treatment for Vascular Leakage During Dengue Fever
Ketotifen, Placebo - Dengue Fever, Pleural Effusion
Phase 4UnknownNational University Hospital, Singapore1102015-03-012016-02-04

Showing 20 of 39. Sign in to see all of them.

Narrower conditions

Malaria (25)  ·  Malaria, Falciparum (8)  ·  Anemia (2)  ·  Encephalitis, Japanese (2)  ·  Encephalitis, Tick-Borne (2)  ·  Malaria, Vivax (2)  ·  Chagas Disease (1)  ·  Coinfection (1)  ·  Death (1)  ·  Dementia (1)  ·  Dengue (1)  ·  Diarrhea (1)  ·  HIV Infections (1)  ·  Heart Failure (1)  ·  Helminthiasis (1)

Broader conditions

Infections (39)  ·  Mosquito-Borne Diseases (34)  ·  Protozoan Infections (33)  ·  Parasitic Diseases (32)  ·  RNA Virus Infections (7)  ·  Virus Diseases (7)  ·  Malaria (6)  ·  Arbovirus Infections (5)  ·  Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Flaviviridae Infections (5)  ·  Flavivirus Infections (5)  ·  Nervous System Diseases (5)  ·  Central Nervous System Infections (4)

Interventions

Artemether, Lumefantrine Drug Combination (10)  ·  Amodiaquine (5)  ·  fanasil, pyrimethamine drug combination (5)  ·  Artesunate (3)  ·  Pyrimethamine (3)  ·  FSME-IMMUN vaccine (2)  ·  Primaquine (2)  ·  atovaquone, proguanil drug combination (2)  ·  bendiocarb (2)  ·  pyronaridine tetraphosphate, artesunate drug combination (2)  ·  Acetaminophen (1)  ·  Albendazole (1)  ·  Aspirin (1)  ·  Azithromycin (1)  ·  Chloroquine (1)

Sponsors

Malaria Consortium (5)  ·  Armed Forces Research Institute of Medical Sciences, Thailand (3)  ·  London School of Hygiene and Tropical Medicine (3)  ·  Makerere University (3)  ·  Charite University, Berlin, Germany (2)  ·  University of Khartoum (2)  ·  University of Yaounde 1 (2)  ·  Banaras Hindu University (1)  ·  Bandim Health Project (1)  ·  Centre national de recherche et de formation sur le paludisme (1)  ·  Federal University of Bahia (1)  ·  KEMRI-Wellcome Trust Collaborative Research Program (1)  ·  Kamuzu University of Health Sciences (1)  ·  Khon Kaen University (1)  ·  Liverpool School of Tropical Medicine (1)

Countries

Uganda (4)  ·  Cambodia (3)  ·  Sudan (3)  ·  Burkina Faso (2)  ·  China (2)  ·  Ghana (2)  ·  Kenya (2)  ·  Nigeria (2)  ·  Vietnam (2)  ·  Austria (1)  ·  Brazil (1)  ·  Guinea-Bissau (1)  ·  India (1)  ·  Malawi (1)  ·  Mozambique (1)

Top investigators

Mariusz Wojnarski, MD (3)  ·  Wilfred Fon Mbacham, PhD (2)  ·  Abraham V Hodgson, MD, MPH, PhD (1)  ·  Adama Gansane, PhD (1)  ·  Anna Rosanas-Urgell, MD, PhD (1)  ·  Annette Olsen, PhD (1)  ·  Ashley L St John (1)  ·  Badara Cisse, PhD (1)  ·  Baltazar Candrinho, MD (1)  ·  Bashir A Ismail, MSc (1)  ·  Celestino Obua, PhD (1)  ·  Chanthap Lon, MD (1)  ·  Cheikh Sokhna, PhD (1)  ·  Craig Bonnington (1)  ·  Daniel Chandramohan, PHD (1)

Results publications

PMID 21631932, PMID 22232457, PMID 22882836, PMID 24736370, PMID 25421474, PMID 25811379, PMID 27764102, PMID 27875528, PMID 29229808, PMID 30326952, PMID 32528467, PMID 32552759, PMID 34031050, PMID 34559992, PMID 35152295, PMID 36149743, PMID 37269941, PMID 38196920, PMID 39826559, PMID 40257829, PMID 41285436, PMID 41382293, PMID 41542944

NIH funding

R01HD079695 (1), R01NS064905 (1)